Medidata, Cognizant form strategic alliance to empower digital transformation

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/BsWei)
(Image: Getty/BsWei)

Related tags: Medidata, Cognizant, Data

Medidata is working with Cognizant to develop a set of services that will provide pharma, biotech, CROs and others with the capabilities to “digitally transform” their research and commercialization.

Medidata and Cognizant have formed a multi-year strategic alliance to develop new solutions for pharmaceutical, biotech, medical device companies, contract research organizations (CROs), sites, and investigators.

Scott Hoffman, senior vice president, global services, solutions and alliances at Medidata, said the goal is to “empower life science organizations of all sizes and therapeutic areas to digitally transform their research and commercialization.”

“As clinical trials become more complex, the key to success is eliminating operational burdens so that researchers can focus on the science of a study,”​ he told us.

Under the agreement, the professional services company Cognizant will develop managed services and solutions specific to Medidata’s platform. As part of this, Medidata Site Payments also will connect with Cognizant’s Shared Investigator Platform (SIP).

Hoffman explained that the combination of professional services with technology and data assets will remove operational barriers, enabling sponsors and CROs to optimize and expand their studies.

“For example, some sponsors and CROs may hesitate to adopt a modern randomization and trial supply management (RTSM) solution without built-in services such as biostats, drug supply management and help desks,”​ he said.

“Wrapping Cognizant services around Medidata’s RTSM solution eliminates this challenge and drives adoption of this critical tool for improving data quality and reducing risk.”

Related news

Show more

Related products

show more

Paper vs ePRO Data Collection Methods

Paper vs ePRO Data Collection Methods

Signant Health | 19-Oct-2021 | Technical / White Paper

Are you curious why more Sponsors choose digital data collection methods over the traditional pen and paper? Read this recent white paper to discover the...

GLP Tissue Cross Reactivity Testing

GLP Tissue Cross Reactivity Testing

Precision for Medicine | 11-Oct-2021 | Product Brochure

Precision for Medicine's unique combination of research services and tissue procurement capabilities form the pillars of our GLP Tissue Cross Reactivity...

Automating clinical trials for success

Automating clinical trials for success

Formedix | 06-Oct-2021 | Technical / White Paper

This article gives gives a brief overview of why automation is absolutely essential for clinical trial success.

Related suppliers

Follow us


View more